GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2026 7:14:08 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $266,044,000 +25.9% | Assets $1,494,112,000 | EPS $1.05 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2026 7:02:00 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $266,044,000 +25.9% | Assets $1,494,112,000 | EPS $1.05 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2026 7:03:43 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $237,462,000 +20.5% | Assets $1,421,970,000 | EPS $1.28 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2026 6:57:50 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $237,462,000 +20.5% | Assets $1,421,970,000 | EPS $1.28 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/9/2026 4:21:06 PM | View | Proxy | SEC | Y 2025 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2026 7:15:21 AM | Mid | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $883,366,000 +43.8% | Assets $1,440,377,000 | EPS $3.32 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2026 7:02:55 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $247,060,000 +29.6% | Assets $1,440,377,000 | EPS $1.17 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 1/12/2026 4:16:39 PM | View | Guidance Update | SEC | 1Q 2026 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 11/7/2025 7:02:51 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $227,813,000 +53.6% | Assets $1,408,152,000 | EPS $1.13 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/7/2025 6:55:49 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $227,813,000 +53.6% | Assets $1,408,152,000 | EPS $1.13 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/8/2025 7:13:58 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $211,371,000 +53.1% | Assets $1,343,001,000 | EPS $0.36 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/8/2025 6:57:53 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $211,371,000 +53.1% | Assets $1,343,001,000 | EPS $0.36 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/9/2025 7:02:30 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $197,122,000 +43.4% | Assets $1,292,428,000 | EPS $0.69 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/9/2025 6:56:40 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $197,122,000 +43.4% | Assets $1,292,428,000 | EPS $0.69 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/10/2025 4:42:28 PM | View | Proxy | SEC | Y 2024 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/28/2025 7:12:08 AM | Mid | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $614,376,000 +26.2% | Assets $1,283,697,000 | EPS -$1.04 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/28/2025 6:55:57 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $190,574,000 +44.8% | Assets $1,283,697,000 | EPS -$0.55 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 1/13/2025 7:23:39 AM | View | Financials | Earnings (Prelim) | SEC | Y 2024 | Export Earnings Model | ||||
| ANI PHARMACEUTICALS INC (ANIP) | 11/8/2024 8:12:26 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $148,332,000 +12.5% | Assets $1,287,377,000 | EPS -$1.27 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/8/2024 6:55:59 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $148,332,000 +12.5% | Assets $1,287,377,000 | EPS -$1.27 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2024 7:05:48 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $138,040,000 +18.4% | Assets $920,753,000 | EPS -$0.14 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2024 6:53:51 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $138,040,000 +18.4% | Assets $920,753,000 | EPS -$0.14 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/10/2024 7:29:42 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $137,430,000 +28.7% | Assets $914,524,000 | EPS $0.82 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/10/2024 6:56:39 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $137,430,000 +28.7% | Assets $914,524,000 | EPS $0.82 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/17/2024 8:03:05 AM | View | Presentation | SEC | 2Q 2024 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 4/5/2024 4:07:28 PM | View | Proxy | SEC | Y 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 3/12/2024 7:08:28 AM | View | Presentation | SEC | 1Q 2024 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/29/2024 7:40:00 AM | Mid | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $486,816,000 +53.9% | Assets $904,422,000 | EPS $0.85 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/29/2024 6:59:02 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $131,654,000 +39.7% | Assets $904,422,000 | EPS $0.02 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/8/2024 8:01:27 AM | View | Presentation | SEC | 1Q 2024 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 1/8/2024 8:31:31 AM | View | Presentation | SEC | 1Q 2024 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 11/15/2023 9:08:25 AM | View | Presentation | SEC | Y 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 11/8/2023 7:16:22 AM | Mid | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $131,829,000 +57.3% | Assets $889,914,000 | EPS $0.45 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/8/2023 6:57:56 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $131,829,000 +57.3% | Assets $889,914,000 | EPS $0.45 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 9/25/2023 4:41:18 PM | View | Presentation | SEC | 3Q 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 9/12/2023 6:02:07 AM | View | Presentation | SEC | 3Q 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 9/7/2023 4:33:36 PM | View | Presentation | SEC | 3Q 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 8/30/2023 7:02:03 AM | View | Presentation | SEC | 3Q 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 8/9/2023 7:15:42 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $116,547,000 +57.8% | Assets $859,341,000 | EPS $0.29 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/9/2023 6:57:36 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $116,547,000 +57.8% | Assets $859,341,000 | EPS $0.29 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 6/9/2023 6:02:46 AM | View | Presentation | SEC | 2Q 2023 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2023 8:45:13 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $106,786,000 +65.6% | Assets $765,224,000 | EPS $0.06 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2023 8:32:30 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $106,786,000 +65.6% | Assets $765,224,000 | EPS $0.06 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/11/2023 4:35:47 PM | View | Proxy | SEC | Y 2022 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 3/9/2023 4:20:28 PM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $316,385,000 +46.4% | Assets $760,087,000 | EPS -$3.05 | |
| ANI PHARMACEUTICALS INC (ANIP) | 3/9/2023 7:04:15 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $94,232,000 +54.7% | Assets $760,087,000 | EPS -$0.29 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/9/2022 5:01:06 PM | View | Conf. Call | SEC | 3Q 2022 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 11/9/2022 9:34:24 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $83,821,000 +61.0% | Assets $739,110,000 | EPS -$0.55 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/9/2022 8:15:59 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $83,821,000 +61.0% | Assets $739,110,000 | EPS -$0.55 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/8/2022 4:18:18 PM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $73,855,000 +51.9% | Assets $751,334,000 | EPS -$0.94 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/8/2022 8:04:03 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $73,855,000 +51.9% | Assets $751,334,000 | EPS -$0.94 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/10/2022 8:46:59 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $64,477,000 +18.3% | Assets $744,846,000 | EPS -$1.27 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/10/2022 8:31:45 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $64,477,000 +18.3% | Assets $744,846,000 | EPS -$1.27 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 3/25/2022 4:59:22 PM | View | Proxy | SEC | Y 2021 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 3/15/2022 8:44:08 AM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $216,136,000 +3.7% | Assets $771,598,000 | EPS -$3.40 | |
| ANI PHARMACEUTICALS INC (ANIP) | 3/15/2022 8:32:26 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $60,929,000 +6.4% | Assets $771,598,000 | EPS -$1.87 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/1/2021 8:44:58 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $52,061,000 -1.7% | Assets $470,454,000 | EPS -$0.37 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/1/2021 8:31:20 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $52,061,000 -1.7% | Assets $470,454,000 | EPS -$0.37 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2021 8:42:56 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $48,625,000 +0.3% | Assets $480,159,000 | EPS -$1.17 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2021 8:32:15 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $48,625,000 +0.3% | Assets $480,159,000 | EPS -$1.17 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/7/2021 8:43:07 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $54,521,000 +9.5% | Assets $463,843,000 | EPS $0.01 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/7/2021 8:31:23 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $54,521,000 +9.5% | Assets $463,843,000 | EPS $0.01 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/29/2021 5:03:06 PM | View | Proxy | SEC | Y 2020 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 3/11/2021 8:44:43 AM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $208,475,000 +0.9% | Assets $461,190,000 | EPS -$1.88 | |
| ANI PHARMACEUTICALS INC (ANIP) | 3/9/2021 8:31:32 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $57,252,000 +19.4% | Assets $461,190,000 | EPS -$0.30 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/5/2020 8:44:47 AM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $52,979,000 +3.2% | Assets $462,581,000 | EPS $0.04 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/5/2020 7:00:00 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $52,979,000 +3.2% | Assets $462,581,000 | EPS $0.04 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2020 8:49:58 AM | Small | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $48,470,000 -10.8% | Assets $465,391,000 | EPS -$1.03 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/6/2020 6:55:34 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $48,470,000 -10.8% | Assets $465,391,000 | EPS -$1.03 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/7/2020 8:43:40 AM | Small | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $49,774,000 -5.9% | Assets $482,232,000 | EPS -$0.59 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/7/2020 8:36:06 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $49,774,000 -5.9% | Assets $482,232,000 | EPS -$0.59 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/23/2020 7:02:10 AM | View | Proxy | SEC | Y 2019 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2020 8:44:02 AM | Small | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $206,547,000 +2.5% | Assets $456,789,000 | EPS $0.50 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2020 8:34:32 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $47,966,000 -16.0% | Assets $456,789,000 | EPS -$0.41 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/6/2019 9:04:39 AM | Small | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $51,337,000 +1.3% | Assets $456,775,000 | EPS $0.32 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/6/2019 8:35:18 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $51,337,000 +1.3% | Assets $456,775,000 | EPS $0.32 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2019 8:41:46 AM | Small | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $54,357,000 +15.0% | Assets $446,906,000 | EPS $0.53 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2019 8:36:53 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $54,357,000 +15.0% | Assets $446,906,000 | EPS $0.53 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/9/2019 9:01:48 AM | Small | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $52,887,000 +13.8% | Assets $434,390,000 | EPS $0.04 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/9/2019 8:37:06 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $52,887,000 +13.8% | Assets $434,390,000 | EPS $0.04 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/4/2019 4:16:53 PM | View | Proxy | SEC | Y 2018 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2019 5:02:07 PM | Small | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $201,576,000 +14.0% | Assets $430,604,000 | EPS $1.30 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2019 8:36:38 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $57,122,000 +20.8% | Assets $430,604,000 | EPS $0.46 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/6/2018 4:38:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $50,703,000 +5.3% | Assets $439,443,000 | EPS $0.42 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/6/2018 8:37:20 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $50,703,000 +5.3% | Assets $439,443,000 | EPS $0.42 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2018 4:46:12 PM | Small | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $47,268,000 +5.6% | Assets $424,177,000 | EPS $0.23 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2018 8:36:49 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $47,268,000 +5.6% | Assets $424,177,000 | EPS $0.23 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2018 4:49:24 PM | Small | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $46,483,000 +26.9% | Assets $418,019,000 | EPS $0.19 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/8/2018 8:36:28 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $46,483,000 +26.9% | Assets $418,019,000 | EPS $0.19 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/6/2018 4:15:44 PM | View | Proxy | SEC | Y 2017 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2018 4:45:10 PM | Small | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $176,842,000 +37.5% | Assets $412,138,000 | EPS -$0.09 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/27/2018 8:36:59 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $47,286,000 +23.8% | Assets $412,138,000 | EPS -$0.83 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/2/2017 8:43:26 AM | Small | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $48,164,000 +25.0% | Assets $370,469,000 | EPS $0.40 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/2/2017 8:35:39 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $48,164,000 +25.0% | Assets $370,469,000 | EPS $0.40 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/3/2017 4:46:22 PM | Small | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $44,764,000 +42.8% | Assets $359,219,000 | EPS $0.23 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/3/2017 8:35:21 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $44,764,000 +42.8% | Assets $359,219,000 | EPS $0.23 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/4/2017 4:44:05 PM | Small | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $36,628,000 +78.2% | Assets $357,138,000 | EPS $0.10 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/4/2017 8:35:35 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $36,628,000 +78.2% | Assets $357,138,000 | EPS $0.10 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/6/2017 4:31:02 PM | View | Proxy | SEC | Y 2016 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 3/2/2017 4:16:46 PM | Small | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $128,622,000 +68.5% | Assets $322,864,000 | EPS $0.34 | |
| ANI PHARMACEUTICALS INC (ANIP) | 3/2/2017 8:35:28 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $38,205,000 +111.8% | Assets $322,864,000 | EPS -$0.09 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/3/2016 4:33:10 PM | Small | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $38,525,000 +92.9% | Assets $319,379,000 | EPS $0.22 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/3/2016 8:35:40 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $38,525,000 +92.9% | Assets $319,379,000 | EPS $0.22 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/4/2016 4:31:52 PM | Small | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $31,337,000 +60.6% | Assets $307,999,000 | EPS $0.10 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/4/2016 8:35:30 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $31,337,000 +60.6% | Assets $307,999,000 | EPS $0.10 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/5/2016 4:31:19 PM | Small | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $20,555,000 +9.3% | Assets $291,588,000 | EPS $0.12 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/5/2016 8:05:40 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $20,555,000 +9.3% | Assets $291,588,000 | EPS $0.12 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/14/2016 8:32:27 AM | View | Proxy | SEC | Y 2015 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/23/2016 4:26:09 PM | Small | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $76,322,000 +36.4% | Assets $285,265,000 | EPS $1.32 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/23/2016 8:05:19 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $18,035,000 -14.3% | Assets $285,265,000 | EPS $0.25 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/3/2015 4:31:45 PM | Small | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $19,972,000 +14.9% | Assets $283,276,000 | EPS $0.39 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/3/2015 8:05:20 AM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $19,972,000 +14.9% | Assets $283,276,000 | EPS $0.39 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/4/2015 4:31:02 PM | Small | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $19,516,000 +193.6% | Assets $270,121,000 | EPS $0.31 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/4/2015 8:01:49 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $19,516,000 +193.6% | Assets $270,121,000 | EPS $0.31 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 7/28/2015 8:25:24 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $19,516,000 +193.6% | Assets $270,121,000 | EPS $0.31 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/5/2015 4:31:01 PM | Small | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $18,799,000 +72.5% | Assets $265,985,000 | EPS $0.38 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/5/2015 8:00:57 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $18,799,000 +72.5% | Assets $265,985,000 | EPS $0.38 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/28/2015 8:01:46 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $18,799,000 +72.5% | Assets $265,985,000 | EPS $0.38 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/24/2015 8:30:21 AM | View | Proxy | SEC | Y 2014 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/23/2015 8:30:45 AM | Small | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $55,970,000 +86.1% | Assets $259,558,000 | EPS $2.59 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/19/2015 8:30:51 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $21,037,000 +99.7% | Assets $259,558,000 | EPS $1.82 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/12/2015 8:30:42 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $21,037,000 +99.7% | Assets $259,558,000 | EPS $1.82 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/10/2014 8:31:06 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $17,387,000 +121.9% | Assets $107,637,000 | EPS $0.59 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/3/2014 8:31:49 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $17,387,000 +121.9% | Assets $107,637,000 | EPS $0.59 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 10/27/2014 12:05:44 PM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $17,387,000 +121.9% | Assets $107,637,000 | EPS $0.59 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 10/27/2014 8:30:54 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $17,387,000 +121.9% | Assets $107,637,000 | EPS $0.59 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/7/2014 8:45:33 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $6,647,000 +8.0% | Assets $95,423,000 | EPS -$0.21 | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/4/2014 8:33:03 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $6,647,000 +8.0% | Assets $95,423,000 | EPS -$0.21 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 7/28/2014 8:35:30 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $6,647,000 +8.0% | Assets $95,423,000 | EPS -$0.21 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/12/2014 8:31:31 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $10,899,000 +96.0% | Assets $96,652,000 | EPS $0.33 | |
| ANI PHARMACEUTICALS INC (ANIP) | 5/5/2014 8:32:23 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $10,899,000 +96.0% | Assets $96,652,000 | EPS $0.33 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/28/2014 8:40:46 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $10,899,000 +96.0% | Assets $96,652,000 | EPS $0.33 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 4/11/2014 4:32:32 PM | View | Proxy | SEC | Y 2013 | ||||||
| ANI PHARMACEUTICALS INC (ANIP) | 2/28/2014 8:30:56 AM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $30,082,000 +47.7% | Assets $44,500,000 | EPS -$0.92 | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/18/2014 8:30:26 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $10,532,000 +435.3% | Assets $44,500,000 | EPS $1.35 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 2/6/2014 8:30:40 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $10,532,000 +435.3% | Assets $44,500,000 | EPS $1.35 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/7/2013 8:33:21 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $7,836,000 +55.6% | Assets $43,285,828 | EPS $0.13 | |
| ANI PHARMACEUTICALS INC (ANIP) | 11/7/2013 8:00:33 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $7,836,000 +55.6% | Assets $43,285,828 | EPS $0.13 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/9/2013 8:30:49 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $6,152,000 +18.6% | Assets $41,658,023 | EPS -$6.03 | Export Earnings Model | |
| ANI PHARMACEUTICALS INC (ANIP) | 8/9/2013 8:30:34 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $6,152,000 +18.6% | Assets $41,658,023 | EPS -$6.03 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 7/2/2013 8:53:45 AM | View | Proxy | SEC | Y 2012 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/10/2013 4:16:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $5,562,000 +4,778.9% | Assets $35,356,386 | ||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/10/2013 4:11:00 PM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $5,562,000 +4,778.9% | Assets $35,356,386 | Export Earnings Model | ||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/1/2013 1:50:09 PM | View | Financials | Earnings | SEC | Y 2012 | Rev $1,967,573 +1,620.3% | Assets $13,748,000 | EPS -$0.16 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 2/28/2013 5:01:01 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $20,371,000 +4,581.3% | Assets $13,748,000 | EPS -$1.27 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/8/2012 4:21:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $5,036,024 +2,655.2% | Assets $43,211,746 | EPS -$1,295.10 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2012 | Rev $5,036,024 +2,655.2% | Assets $43,211,746 | EPS -$1,295.10 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 8/1/2012 5:09:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $5,186,793 +6,303.2% | Assets $47,294,679 | EPS -$1,644.86 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 8/1/2012 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2012 | Rev $5,186,793 +6,303.2% | Assets $47,294,679 | EPS -$1,644.86 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/8/2012 4:45:33 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $114,000 +100.0% | Assets $54,574,918 | EPS -$0.53 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/8/2012 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2012 | Rev $114,000 +100.0% | Assets $54,574,918 | EPS -$0.53 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 4/9/2012 4:15:34 PM | View | Proxy | SEC | Y 2011 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/13/2012 5:11:21 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $435,160 -82.4% | Assets $62,379,755 | EPS -$3.15 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/13/2012 12:00:00 AM | View | Financials | Earnings | SEC | Y 2011 | Rev $114,373 -20.0% | Assets $62,379,755 | EPS -$0.29 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/9/2011 4:47:04 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $182,784 +256.1% | Assets $74,890,908 | EPS -$0.73 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/9/2011 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $182,784 +256.1% | Assets $74,890,908 | EPS -$0.73 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 8/5/2011 4:30:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $81,003 | Assets $42,763,850 | EPS -$0.16 | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 7/25/2011 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $81,003 | Assets $42,763,850 | EPS -$0.16 | Export Earnings Model | |
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/10/2011 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2011 | Rev $57,000 | EPS -$1.22 | Export Earnings Model | ||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 4/11/2011 7:31:06 AM | View | Proxy | SEC | Y 2010 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/16/2011 12:00:00 AM | View | Financials | Earnings | SEC | Y 2010 | Rev $143,032 | EPS -$3.70 | Export Earnings Model | ||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/12/2010 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2010 | Rev $51,331 | Export Earnings Model | |||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 8/12/2010 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2010 | EPS -$0.17 | Export Earnings Model | |||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/14/2010 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2010 | Export Earnings Model | ||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 4/29/2010 6:00:53 AM | View | Proxy | SEC | Y 2009 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 4/29/2010 6:00:53 AM | View | Proxy | SEC | Y 2009 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/30/2010 12:00:00 AM | View | Financials | Earnings | SEC | Y 2009 | Export Earnings Model | ||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 11/9/2009 12:00:00 AM | View | Financials | Earnings | SEC | 3Q 2009 | Export Earnings Model | ||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 8/7/2009 12:00:00 AM | View | Financials | Earnings | SEC | 2Q 2009 | Export Earnings Model | ||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 5/11/2009 12:00:00 AM | View | Financials | Earnings | SEC | 1Q 2009 | Export Earnings Model | ||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 4/27/2009 11:56:12 AM | View | Proxy | SEC | Y 2008 | ||||||
| BIOSANTE PHARMACEUTICALS INC (ANIP) | 3/16/2009 12:00:00 AM | View | Financials | Earnings | SEC | Y 2008 | Export Earnings Model |